Increased Domestic Production Guarantees
Consistent Availability
NEWTOWN
SQUARE, Pa., June 18,
2024 /PRNewswire/ -- Kibow® Biotech has announced
that its popular kidney health supplement, Renadyl™, is back in
stock and will remain consistently available, due to expanded
domestic manufacturing capabilities.
In response to the overwhelming demand from both doctors and
patients worldwide, Kibow® Biotech has significantly increased its
US-based production capacity. This enhancement ensures a consistent
supply of Renadyl™, which has become a vital part of kidney health
routines for many individuals managing the different stages of
chronic kidney disease (CKD).
"We are proud to have Renadyl™ back in stock and in such high
demand," said Michael Kane,
Executive Vice President at Kibow® Biotech. And going
forward, we are thrilled that our additional domestic manufacturing
capabilities will be able to guarantee that Renadyl™ is always at
its highest quality and in stock."
Kane added, "We understand the critical role Renadyl™ plays in
supporting kidney health, and we sincerely apologize for any
inconvenience caused by our recent inventory shortages."
Kibow® Biotech remains committed to empowering individuals with
CKD to live life on their own terms. Renadyl™, the company's
probiotic and prebiotic kidney health supplement, is demonstrated
to support kidney function and improve overall well-being, offering
a natural option for those seeking to support their kidney
health.
Renadyl™ – the #1 nephrologist-recommended probiotic supplement
for kidney health – is an all-natural, non-GMO, gluten-free, and
non-prescription product available online throughout the US on
Amazon and at Renadyl.com.
About Kibow® Biotech, Inc.: Kibow® Biotech
specializes in research, development, and commercialization of
probiotic dietary supplements adhering to US FDA and FTC
regulations. Founded October 1, 1997,
in Philadelphia, PA, the company's
primary mission is to offer affordable, readily available, and
easily administered nutritional supplements to support kidney
health and other healthcare applications. Kibow® Biotech's
extensive scientific (R&D) and clinical data from three
different pilot/observational scientific human clinical trials has
been published in peer-reviewed scientific/medical journals
(kibowbiotech.com/rd), and the company's flagship product,
Renadyl™, is marketed in the US, Canada, and several other countries as a
kidney dietary supplement product in adherence with each country's
governmental rules and regulatory authorities.
Contact Information:
Michelle
Adams
President
PRISM Marketing
614-989-6373
michelle@prismmarketing.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-1-nephrologist-recommended-kidney-probiotic-renadyl-is-back-in-stock-302175706.html
SOURCE Kibow Biotech